Tag Archives: ENI

Hot Medical Stocks To Watch For 2021

President Donald Trump introduced his 2019 budget blueprint on Monday. He makes some pretty unrealistic claims about how his current proposals would reduce deficits.

His budget proposes to slash them by more than $3 trillion over the next decade, bringing the annual deficit down from 4.4% of GDP this year to 1.1% by 2028.

How? Largely by proposing severe spending cuts combined with optimistic growth projections of roughly 3% a year.

Never mind that he recently signed into law two deficit-increasing bills. The federal tax overhaul plus a two-year increase in spending caps will push the country to start running $1 trillion-plus annual deficits next year.

“The depth of the budgetary hole that has been dug over the past year is made clear by the fact that the administration could not produce a balanced budget even with unrealistic growth assumptions and scoring gimmicks,” said Robert L. Bixby, executive director of The Concord Coalition, a nonpartisan fiscal watchdog.

Hot Medical Stocks To Watch For 2021: El Paso Electric Company(EE)

El Paso Electric Company (the “Company”) is a public utility engaged in the generation, transmission and distribution of electricity in an area of approximately 10,000 square miles in west Texas and southern New Mexico. The Company also serves a full requirements wholesale customer in Texas. The Company owns or has significant ownership interests in several electrical generating facilities providing it with a net dependable generating capability of approximately 2,055 MW. For the year ended December 31, 2015, the Company’s energy sources consisted of approximately 47% nuclear fuel, 34% natural gas, 6% coal, 13% purchased power and less than 1% generated by Company-owned solar photovoltaic panels and wind turbines. The Company continues to expand its portfolio of renewable energy sources, particularly solar photovoltaic generation. As of December 31, 2015, the Company has power purchase agreements for 107 MW from solar photovoltaic generation facilities.   Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on El Paso Electric (EE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Korea Electric Power (NYSE: KEP) and El Paso Electric (NYSE:EE) are both utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends.

  • [By Ethan Ryder]

    Shares of El Paso Electric (NYSE:EE) have been assigned a consensus recommendation of “Hold” from the seven ratings firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $51.33.

Hot Medical Stocks To Watch For 2021: Itron Inc.(ITRI)

Itron, Inc. provides products and services for the energy and water markets worldwide. It produces standard electricity, natural gas, and water meters for residential, commercial, industrial, and transmission and distribution customers. The company also offers advanced and smart electronic, gas, and water meters, as well as communication modules; handheld, mobile, and fixed network collection technologies; meter data management software; prepayment systems comprising smart key, keypad, and smart card communication technologies; data warehousing; and knowledge application solutions. It provides communication technologies, which include telephone, radio frequency, global system for mobile communications, power line carrier, and Ethernet devices. In addition, the company offers professional services, including implementation, installation, consulting, system management, and analysis. It markets its products through direct sales, distributors, representative agencies, partners , and meter manufacturer representatives. The company was founded in 1977 and is headquartered in Liberty Lake, Washington.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Itron Inc (NASDAQ:ITRI)Q42018 Earnings Conference CallFeb. 27, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Itron (ITRI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Watch For 2021: Enersis S A(ENI)

Enersis S.A., an electric utility company, engages in the generation, transmission, and distribution of electricity in Chile, Argentina, Brazil, Colombia, and Peru. It owns and operates hydroelectric, thermal, and wind power plants. As of December 31, 2010, it had 14,833 megawatts of installed capacity with 195 power plants; and 13.3 million distribution customers covering approximately 50 million inhabitants. The company was formerly known as Compania Chilena Metropolitana de Distribucion Electrica S.A and changed its name to Enersis S.A. in August 1988. Enersis S.A. was founded in 1889 and is headquartered in Santiago, Chile. Enersis S.A. is a subsidiary of Endesa Latinoamerica S.A.

Advisors’ Opinion:

  • [By Shane Hupp]

    JPMorgan Chase & Co. set a €15.00 ($17.44) price objective on ENI (ETR:ENI) in a report published on Thursday morning. The firm currently has a sell rating on the stock.

  • [By Stephan Byrd]

    Morgan Stanley set a €16.70 ($19.42) price objective on ENI (ETR:ENI) in a report issued on Wednesday morning. The firm currently has a sell rating on the stock.

  • [By Shane Hupp]

    ENI (ETR:ENI) has been assigned a €18.50 ($21.76) price objective by equities researchers at Deutsche Bank in a note issued to investors on Tuesday. The brokerage currently has a “buy” rating on the stock. Deutsche Bank’s price objective points to a potential upside of 13.26% from the stock’s current price.

Hot Medical Stocks To Watch For 2021: Spok Holdings, Inc.(SPOK)

Spok Holdings, Inc., incorporated on March 5, 2004, is a holding company. The Company, through its indirect subsidiary, Spok, Inc., provides critical communication solutions for enterprises. The Company offers critical communication for healthcare, government, public safety and other industries. The Company’s segment is critical communication business. The Company offers paging services and selected software solutions in the United States and abroad, generally in Europe, Canada, Australia, Asia and the Middle East. The Company offers its services and products primarily to three market segments: healthcare, government and large enterprise. The Company also offers implementation services for its products.

Paging Services

The Company offers subscriptions to one-way or two-way messaging services for a periodic (monthly, quarterly, semi-annual, or annual) service fee. A subscriber to one-way messaging services select coverage on a local, regional or nationwide basis as per their messaging needs. Two-way messaging is offered on a nationwide basis. In addition, subscribers either lease a messaging device from the Company for an additional fixed monthly fee or own a device, having purchased it either from the Company or from another vendor. The Company also sells devices to resellers who lease or resell devices to their subscribers and then sell messaging services utilizing the Company’s networks. The Company also offers ancillary services, such as voicemail and equipment loss or maintenance protection.

Software

The Company offers a range of solutions, providing its customers with the ability to communicate anywhere, anytime across a number of situations. Its solutions are used for contact centers, clinical alerting and notification, mobile communications and messaging and for public safety notifications. The Company’s critical communication solutions are grouped under four product categories: Contact Center, Clinical Alerting, Mobile Communications and Publ! ic Safety.

The Contact Center category includes Spok Healthcare Console, Spok Web-Based Directory, Spok Web-Based On-Call Scheduling, Spok Speech, HigherGround Call Recording and Quality Management, and Eclipse Call Accounting. Spok Healthcare Console provides operators with the information needed to process calls using their computers. This solution integrates with the customers’ existing phone systems and is used by the operator group to answer incoming calls to the contact center. Operators can perform directory searches and code calls, as well as messaging and paging by individual, groups and roles using the Spok Healthcare Console’s computer telephony integration (CTI) and directory capabilities.

Spok Web-Based Directory provides employee contact information and enables staff to send messages from the directory. Authenticated users can log on to perform updates to contact information and on-call schedules, search the directory and send important messages. Spok Web-Based On-Call Scheduling keeps personnel, calendars and on-call scheduling information updated, using a Web portal to maintain and allow password-protected access to the latest on-call schedules and personnel information.

Spok Speech enables the organization to process routine phone requests, including transfers, directory assistance, messaging and paging, without live operators. HigherGround Call Recording and Quality Management records, monitors and scores operators’ conversations. Eclipse Call Accounting provides information about every call being made and received. The information can be formatted and used to analyze voice network resources, employee telephone usage and bill-back information.

The Company’s Clinical Alerting category includes Spok Messenger and Fusion, Spok e.Notify and Spok Critical Test Results Management. Spok Messenger and Fusion provides the United States Food and Drug Administration (FDA) 510(k)-cleared solution that connects virtually all alert systems, includi! ng nurse ! call, fire, security, patient monitoring and building management to mobile staff through their wireless communication devices. Spok e.Notify enables organizations to notify and confirm team member availability during emergency situations. This solution automatically delivers messages, collects responses, escalates issues to others and logs all activities for reporting and analysis purposes. Spok Critical Test Results Management automates the process of delivering critical test results to the right clinicians. This solution can send messages from the cardiology, laboratory and radiology departments by means of encrypted smartphone communications, two-way paging, secure e-mail, secure text, images, annotations and voice to a range of endpoints, such as workstations, laptops, tablets, smartphones, pagers and other wireless devices.

The Company’s Mobile Communications category comprises Spok Mobile, Spok Pagers and Transmitters, and Spok Device Preference Engine. Spok Mobile uses smartphones and tablets for secure code alerts, patient updates, lab results, and consult requests, among others. It allows users to access the directory of contact information, to send messages, photos and videos to smartphones and other devices. Spok Pagers and Transmitters provide communications through paging system. Spok Device Preference Engine facilitates voice conversations among doctors and caregivers based on their schedules by enabling users to choose the desired communication method based on the situation, urgency, time and date.

The Company’s Public Safety category consists of Spok pc/psap and Spok Enterprise Alert. Spok pc/psap is used for emergency dispatch by giving the Public Service Answering Point (PSAP) call-takers standards-based, graphical interface that integrates the underlying phone system, mapping systems and other resources for critical information availability. Spok Enterprise Alert directs emergency personnel to a 9-1-1 caller’s exact location, such as building, floor and room.! The E9-1! -1 software provides real time, onsite notification when 9-1-1 is dialed.

The Company competes with American Messaging Service, LLC, AT&T Mobility LLC, Sprint Nextel Corporation, T-Mobile USA, Inc. and Verizon Wireless, Inc.

Advisors’ Opinion:

  • [By Shane Hupp]

    News stories about Spok (NASDAQ:SPOK) have trended somewhat positive recently, Accern Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Spok earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave news articles about the Wireless communications provider an impact score of 46.0015198315013 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Logan Wallace]

    Spok (NASDAQ: SPOK) and Mobil’nye Telesistemy PAO (NYSE:MBT) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership.

Hot Medical Stocks To Watch For 2021: BankUnited, Inc.(BKU)

BankUnited, Inc., incorporated on April 28, 2009, is the bank holding company of BankUnited, National Association (the Bank). The Bank provides a range of banking services to individual and corporate customers through approximately 100 branches. The Bank also provides commercial lending products on a national platform.

Lending Activities

The Company offers a range of lending products, including small business loans, commercial real estate loans, equipment loans and leases, term loans, formula-based loans, municipal loans and leases, commercial lines of credit, letters of credit and consumer loans. It also purchases performing residential loans through established correspondent channels on a national basis. The Company’s loan portfolio includes approximately $15.8 billion in loans originated or purchased, or new loans, including approximately $12.8 billion in commercial and commercial real estate loans, approximately $2.9 billion in residential loans and over $35 million in consumer loans. The Company’s commercial loans, which are made to growing companies and middle-market businesses, include equipment loans, secured and unsecured commercial and working capital lines of credit, formula-based loans, mortgage warehouse lines, taxi medallion loans, letters of credit, Small Business Administration (SBA) product offerings and business acquisition finance credit facilities. The Company offers term financing for the acquisition or refinancing of properties, rental apartments, mixed-use commercial properties, industrial properties, warehouses, retail shopping centers, free-standing single-tenant buildings, office buildings and hotels. Other products that it provides include real estate secured lines of credit, acquisition, development and construction loan facilities and construction financing.

The Company makes commercial real estate loans secured by both owner-occupied and non-owner occupied properties. Through the Bank’s commercial lending subsidiaries, it provides mu! nicipal and equipment financing on a national basis. Pinnacle Public Finance, Inc. (Pinnacle) offers essential use equipment financing to municipalities through both loan and direct finance lease structures. United Capital Business Lending, Inc. (UCBL) offers small business equipment leases and loans with a focus on franchise equipment finance. Bridge Capital Leasing, Inc (Bridge) provides transportation equipment finance through loan, direct finance lease and operating lease structures. The Company’s portfolio of one- to four-single family residential loans includes approximately $2.4 billion of purchased loans and approximately $475 million of originated loans. It offers consumer loans to its customers for personal, family and household purposes, including auto, boat and personal installment loans. The Company services SBA loans originated and sold into the secondary market. The Company’s total loans are approximately $16.6 billion.

Investment Activities

The Company’s investment securities are classified as investment securities available for sale and investment securities held to maturity. Its investment securities available for sale include the United States treasury securities, the United States Government agency and sponsored enterprise residential mortgage-backed securities, the United States Government agency and sponsored enterprise commercial mortgage-backed securities, resecuritized real estate mortgage investment conduits, private label residential mortgage-backed securities and collateralized mortgage obligations, private label commercial mortgage-backed securities, single family rental real estate-backed securities and collateralized loan obligations, among others. Its total investment securities available for sale are approximately $4.8 billion. Its investment securities held to maturity consists of a State of Israel bond with a carrying value of over $10 million.

Sources of Funds

The Company’s sources of funds include management fees an! d dividen! ds from the Bank, access to public debt and capital markets and available for sale securities portfolio. It offers deposit products, including checking accounts, money market deposit accounts, savings accounts and certificates of deposit with various terms and rates. The Company’s total deposits are approximately $16.9 billion.

The Company competes with Bank of America, BB&T, BBVA Compass, HSBC, JPMorgan Chase, PNC, Regions Bank, Santander, Sabadell, SunTrust Banks, TD Bank, Wells Fargo, Capital One, Signature Bank, New York Community Bank, Valley National and M&T Bank.

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of BankUnited (NYSE:BKU) have received an average rating of “Hold” from the thirteen research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $40.70.

  • [By Peter Graham]

    1) Mid cap BankUnited, Inc (NYSE: BKU) seems well positioned to cash in on the migration from high tax states to Florida. With total assets of $32.2 billion at December31, 2018, the Miami Lakes based bank has80 banking centers in 15 Florida counties and 5 banking centers in the New York metropolitan area.

Hot Medical Stocks To Watch For 2021: Vera Bradley Inc.(VRA)

Vera Bradley, Inc., through its subsidiary, Vera Bradley Designs, Inc., engages in the design, production, marketing, and retail of functional accessories for women under the ?Vera Bradley? brand. Its products include a range of handbags, accessories, and travel and leisure items. The company sells its products to independent retailers located in the United States, as well as to national retailers and third party e-commerce sites. As of January 29, 2011, Vera Bradley, Inc. sold its products directly through 35 full-price stores, 4 outlet stores, verabradley.com, and an annual outlet sale in Fort Wayne, Indiana. The company was founded in 1982 and is headquartered in Fort Wayne, Indiana.

Advisors’ Opinion:

  • [By Steve Symington]

    As for individual stocks, Aurora Cannabis (NYSE:ACB) popped after bringing on a promising new strategic advisor, while Vera Bradley (NASDAQ:VRA) soared on a strong quarterly report.

  • [By Garrett Baldwin]

    THREE STOCKS: Any one of these cannabis companies could potentially deliver a 1,000% windfall. Click here to learn more…

    Finally, oil prices pushed higher Wednesday thanks to a dip in exports out of Saudi Arabia and Venezuela. As we’ve noted, the Saudi government is looking to press crude prices higher by reducing OPEC output and limiting shipments to Asia. Those cuts come as economic sanctions continue to weigh on the Venezuelan oil market. The United States imported 500,000 barrels of Venezuelan crude in November 2018, but sanctions will dry up that flow of oil to the United States. With oil prices set to rise in the coming months, we’ve identified the top energy stock to buy in March. Best of all, it’s under $10 per share.
    Stocks to Watch Today: EXPR, BA, TSLA
    Shares of Express Inc. (NASDAQ: EXPR) are off more than 13% this morning after the retail firm issued extremely weak guidance before the bell Wednesday. Although the retail firm topped EPS estimates, it reported a 6% drop in same-store sales to complement a decline in revenue. The firm called its earnings report “disappointing” and listed a series of other challenges that face the company in 2019. Just don’t buy the stock. Shares of Boeing Co.(NYSE: BA) were off in pre-market hours as the global aviation giant continued to reel from last weekend’s Ethiopia Air crash. Countries around the globe are grounding Boeing Air MAX 9 jets until further maintenance and updates are provided by the company. China, Australia, Indonesia, and the European Union have grounded Air 737 MAX 8 flights, and investors are worried that the second crash in five months for one of these planes will cause a delay in orders. BA stock is off 11% in the last two days. Shares of Tesla Inc. (NASDAQ: TSLA) were off in pre-market hours thanks to a negative investor report from Goldman Sachs Group Inc. (NYSE: GS). Goldman issued a “Sell” rating for the stock and projected a weaker price for TSLA stock over concerns about fa

  • [By Timothy Green]

    Shares of Vera Bradley (NASDAQ:VRA) soared on Wednesday following a fourth-quarter report that beat expectations. The fashion specialist’s revenue and earnings came in ahead of analyst estimates, and its full-year guidance was better than expected. As of 11:55 a.m. EDT, the stock was up about 19.9%.

  • [By Logan Wallace]

    Vera Bradley (NASDAQ:VRA) and Capri (NYSE:CPRI) are both retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, profitability, risk and valuation.

Top 10 Blue Chip Stocks To Invest In Right Now

Shutterstock

A few weeks ago we discussed how you can make 12% annually, forever, from stocks. Now let’s apply those lessons to 2017, and highlight five that should do even better (17%+ returns) this year (and likely beyond).

Remember, projecting our returns from any given stock is simple. We simply add together the three ways it can pay us:

Its current dividend.

A future dividend hike.

Share repurchases.

It also helps if the stock is inexpensive, as buybacks deliver more bang for management’s buck. So let’s stick with stocks that are dirt-cheap, trading for 10-times free cash flow (FCF) or less for this exercise.

Here’s an example of a stock ready to return 17% or more over the next year. Blue chip refiner Valero (VLO) has a great management team that knows how to make money no matter what happens with energy prices.

Top 10 Blue Chip Stocks To Invest In Right Now: Nuveen Connecticut Premium Income Municipal Fund(NTC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Media stories about Nuveen Connecticut Premium Income Mun Fd (NYSE:NTC) have trended very positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nuveen Connecticut Premium Income Mun Fd earned a news sentiment score of 0.53 on Accern’s scale. Accern also gave news stories about the investment management company an impact score of 47.4041994466706 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: Carpenter Technology Corporation(CRS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    ValuEngine cut shares of Carpenter Technology (NYSE:CRS) from a buy rating to a hold rating in a research note published on Monday morning.

    Other equities research analysts also recently issued reports about the company. Cowen reiterated a buy rating and issued a $66.00 target price on shares of Carpenter Technology in a research report on Friday, June 1st. Zacks Investment Research upgraded Carpenter Technology from a sell rating to a hold rating in a research report on Monday, April 16th. Deutsche Bank boosted their target price on Carpenter Technology from $47.00 to $49.00 and gave the stock a hold rating in a research report on Wednesday, April 11th. Finally, Longbow Research downgraded Carpenter Technology from a buy rating to a neutral rating and set a $50.00 target price on the stock. in a research report on Monday, June 25th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Carpenter Technology presently has an average rating of Hold and a consensus target price of $56.50.

  • [By Ethan Ryder]

    Titan International (NYSE: TWI) and Carpenter Technology (NYSE:CRS) are both industrial products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

  • [By Logan Wallace]

    Carpenter Technology Co. (NYSE:CRS) VP Timothy Lain sold 1,007 shares of the firm’s stock in a transaction that occurred on Friday, May 4th. The stock was sold at an average price of $55.00, for a total transaction of $55,385.00. Following the completion of the transaction, the vice president now directly owns 11,288 shares of the company’s stock, valued at $620,840. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 10 Blue Chip Stocks To Invest In Right Now: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    State Bank Financial (NASDAQ:STBZ) last issued its quarterly earnings results on Thursday, January 25th. The financial services provider reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. State Bank Financial had a return on equity of 9.26% and a net margin of 18.77%. The firm had revenue of $68.16 million during the quarter, compared to the consensus estimate of $65.00 million. analysts expect that State Bank Financial will post 2.18 EPS for the current year.

    TRADEMARK VIOLATION WARNING: “Analysts Set State Bank Financial (STBZ) PT at $34.00” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3379591/analysts-set-state-bank-financial-stbz-pt-at-34-00.html.

    State Bank Financial Company Profile

Top 10 Blue Chip Stocks To Invest In Right Now: SmartFinancial, Inc.(SMBK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on SmartFinancial (SMBK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Invest In Right Now: Enersis S A(ENI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    HSBC set a €18.20 ($21.16) price objective on ENI (ETR:ENI) in a research note published on Monday morning. The brokerage currently has a buy rating on the stock.

  • [By Stephan Byrd]

    Deutsche Bank set a €18.50 ($21.51) price target on ENI (ETR:ENI) in a report released on Thursday. The brokerage currently has a buy rating on the stock.

  • [By Joseph Griffin]

    Headlines about Enel Americas (NYSE:ENI) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Enel Americas earned a news sentiment score of 0.04 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 44.8569330191595 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: AxoGen, Inc.(AXGN)

Advisors’ Opinion:

  • [By Lee Jackson]

    Jefferies started coverage on this top biotech/medtech firm last year with a Buy rating. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

  • [By Joseph Griffin]

    These are some of the media stories that may have impacted Accern’s analysis:

    Get AxoGen alerts:

    Analysts Anticipate AxoGen, Inc (AXGN) Will Announce Earnings of -$0.06 Per Share (americanbankingnews.com) The SVP Sales of AxoGen (NASDAQ: AXGN) is Selling Shares (analystratings.com) BRIEF-Axogen Inc Says On May 15, Board Elected CEO Zaderej To Succeed Grooms As Chairman (reuters.com) AxoGen, Inc (AXGN) SVP Shawn F. Mccarrey Sells 10,000 Shares (americanbankingnews.com) Global Nerve Repair Biomateria Market Report 2018-2023 -Axogen, Integra, Synovis, Collagen Matrix, Polyganics … (talkdailynews.com)

    AxoGen opened at $43.95 on Monday, Marketbeat reports. AxoGen has a fifty-two week low of $13.95 and a fifty-two week high of $46.00. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.81 and a current ratio of 3.32. The company has a market cap of $1.52 billion, a P/E ratio of -141.77 and a beta of -0.04.

  • [By Shane Hupp]

    AxoGen, Inc (NASDAQ:AXGN) – Analysts at William Blair raised their Q2 2018 earnings estimates for AxoGen in a research report issued on Monday, May 14th. William Blair analyst K. Krum now expects that the medical equipment provider will post earnings per share of ($0.04) for the quarter, up from their prior forecast of ($0.05). William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for AxoGen’s Q4 2018 earnings at ($0.03) EPS and FY2018 earnings at ($0.25) EPS.

  • [By Lee Jackson]

    This is another biotech/medical technology that Jefferies started coverage on with a Buy rating late last year. AxoGen Inc. (NASDAQ: AXGN) offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane.

Top 10 Blue Chip Stocks To Invest In Right Now: Knowles Corporation(KN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    These are some of the news articles that may have impacted Accern Sentiment’s scoring:

    Get Knowles alerts:

    Head to Head Contrast: Knowles (KN) vs. Sony (SNE) (americanbankingnews.com) Knowles (KN) Given Consensus Rating of “Hold” by Analysts (americanbankingnews.com) Four seniors nab scholarships from Siouxland Officials Association (siouxcityjournal.com) When is Who Dares Wins on BBC One tonight, how old is host Nick Knowles and how does the game show work? (thesun.co.uk) Local students learn the art of architecture (dailytidings.com)

    KN has been the subject of several research analyst reports. Craig Hallum restated a “buy” rating and set a $17.00 price target (down from $20.00) on shares of Knowles in a research report on Thursday, February 8th. Zacks Investment Research lowered Knowles from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. ValuEngine lowered Knowles from a “hold” rating to a “sell” rating in a research report on Monday, April 2nd. JPMorgan Chase lowered their price target on Knowles from $16.00 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, April 24th. Finally, Lake Street Capital lowered their price target on Knowles from $19.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, February 8th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $17.29.

  • [By Stephan Byrd]

    Sony (NYSE: SNE) and Knowles (NYSE:KN) are both consumer discretionary companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, profitability, analyst recommendations, risk and valuation.

  • [By Joseph Griffin]

    Liberty Mutual Group Asset Management Inc. lowered its stake in shares of Knowles (NYSE:KN) by 22.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,610 shares of the communications equipment provider’s stock after selling 5,088 shares during the period. Liberty Mutual Group Asset Management Inc.’s holdings in Knowles were worth $222,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Knowles (KN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.

    SVB Financial Group (NASDAQ: SIVB) shares were also up, gaining 19 percent to $305.90 following strong quarterly results.

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top 10 Blue Chip Stocks To Invest In Right Now: Midatech Pharma PLC(MTP)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

  • [By Logan Wallace]

    News articles about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Midatech Pharma earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave press coverage about the company an impact score of 47.6134155747452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Shane Hupp]

    Media stories about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Midatech Pharma earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.0428548550507 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on S&w Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

  • [By Ethan Ryder]

    S&w Seed (NASDAQ:SANW) – Equities researchers at B. Riley decreased their Q3 2019 earnings per share (EPS) estimates for S&w Seed in a research note issued to investors on Thursday, May 10th. B. Riley analyst S. Sherbetchyan now anticipates that the company will post earnings of $0.00 per share for the quarter, down from their previous forecast of $0.01. B. Riley has a “Buy” rating and a $5.50 price objective on the stock.

  • [By Logan Wallace]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

Top 10 Blue Chip Stocks To Invest In Right Now: Flanigan’s Enterprises Inc.(BDL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st